Trial Profile
Lansoprazole [PrevOnco] and doxorubicin in patients with solid tumours refractory to sorafenib
Status:
Planning
Phase of Trial:
Phase III
Latest Information Update: 08 Nov 2010
Price :
$35
*
At a glance
- Drugs Lansoprazole (Primary) ; Doxorubicin
- Indications Solid tumours
- Focus Therapeutic Use
- 06 Nov 2010 New trial record